Home > Drug Search >
  • company_query: Baliopharm AG
  •   > 
Drug Filter
Category:
chemistry (4) biology (22)
Status:
Approved (2) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (11) Phase Ⅰ (7)
Clinical Stage:
Pending (2) Active (18) Discontinued (4)
Bio-Type:
Coagulation factor (1) CAR T cell therapy (2) Vaccine (1) Other recombinant protein (1) Single-chain FV antibody fragment (scFv) (1) Whole antibody (8) ADC (1) Fusion protein (2)
Indication:
Breast cancer (2) Rectal cancer (1) Crohn's disease (1) Cutaneous T cell lymphoma (CTCL) (1) Dry eye disease (1) wound (1) Gastric cancer (3) HBV infection (1) Afibrinogenaemia (1) Lung cancer (1) Melanoma (1) Multiple myeloma (MM) (1) Non-Hodgkin’s lymphoma (NHL) (2) Osteoarthritis (OA) (1) Ovarian cancer (1) Pancreatic cancer (2) Prostate cancer (1) Rheumatoid arthritis (RA) (2) Schizophrenia (1) Seasonal allergic rhinitis (1) Solid tumours (1) Uveitis (1) Head and neck cancer (1) Influenza A virus infections (1) Colorectal cancer (3) Neuroblastoma (1) Behcet's disease (1) Sickle cell disease (1) Hemophilia A (1) Neutropenia (1) Renal carcinoma (1) Autoimmune diseases (1) Glioblastoma (1) Plaque psoriasis (1) Allergic asthma (1) Thelassemia (1) Inflammation (1) Human papillomavirus infections (HPV) (1) Ocular inflammation (1)
Country:
Aprv. Year:
 (1) 2012 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top